FOR IMMEDIATE RELEASE GE Research receives record amount of NIH awards, Union prof’s neuro-exergame in clinical trials ALBANY, NEW YORK – In fiscal 2020, the Capital Region’s Life Sciences Cluster received its greatest amount of National Institutes of Health (NIH) awards in 12 years, when adjusting for inflation. The
FOR IMMEDIATE RELEASE Region’s biopharma industry gets new training center in January with ACPHS’s CBET ALBANY, NEW YORK – While Regeneron Pharmaceuticals’ East Greenbush plant attracts global interest for making its COVID-19 antibody cocktail consisting of two active pharmaceutical ingredients (APIs), there are several other facilities in the Capital Region
Featured university R&D projects: 30-Minute COVID-19 Antibody Test Unique System for Using UVC Light to Sterilize Masks in Bulk Diagnostic Saliva COVID-19 Test Rapid Corona Virus Testing Engineers Developing New Ways to Optimize N95 Masks COVID-19 Pooled Surveillance Testing Program Streamlined Temperature Screening System UB facilities used to develop COVID-19
Featured R&D projects: Transfer RNAs in Cancer Improving Targeted Therapies against Solid Tumors Targeting the Chaperone of Kidney Cancer Choice of anesthesia may affect breast metastases New inhibitor shows promise against metastatic prostate cancer A Tumor Model that More Closely Mimics the Body Protein Linked to Cancer Acts as a
See CEG’s latest industry attraction promotional reports on key industry clusters and regional/county profiles. Between 2015 and 2019, CEG promoted the Capital Region at 78 industry attraction events in 41 cities worldwide. While the coronavirus pandemic has temporarily halted CEG’s travel to conferences, we continue to represent the region at
(June 16, 2020; Glens Falls, New York) – As the coronavirus pandemic underscores the importance of the domestic manufacturing of medical equipment and supplies, new U.S. Bureau of Labor Statistics (BLS) data is revealing for the first time that Warren County, New York, has the nation’s highest concentration of jobs
From conducting clinical trials to developing testing equipment and medical devices, the Capital Region’s Life Sciences Cluster is contributing to the effort to fight the coronavirus pandemic. The Life Sciences Cluster employs more than 5,800 and features several industries that are nationally unique. Below is an overview of COVID-19-related activates
National Institutes of Health (NIH) awards in the Capital Region climbed to an 11-year high in fiscal 2019, driven by a surge in R&D funding at AMRI, GE Global Research, Rensselaer Polytechnic Institute (RPI) and Albany Medical Center, according to a Center for Economic Growth (CEG) analysis.1 “These NIH awards
The pharmaceutical industry has started conducting hundreds of clinical trials at Capital Region medical facilities in recent years, and more drug testing is expected as the local Life Sciences Cluster vastly expands with several multimillion-dollar projects. Emerging Clinical Trial Support Assets The pharmaceutical industry funded 342 clinical trials for drug
R&D spending on life sciences increased by nearly 18 percent to $126.7 million in fiscal 2018. That was a four-year high for local R&D spending in that field, according to a Center for Economic Growth (CEG) analysis of new data from the Nation Center for Science and Engineering Statistics. The
